Pricing Log in Create free account

NeuroSense Therapeutics Ltd. (NRSN) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NeuroSense Therapeutics Ltd. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. NeuroSense Therapeutics Ltd. and Reviva Pharmaceuticals Holdings, Inc. are of similar size ($5.0M and $4.6M). Across the 7 metrics below, Reviva Pharmaceuticals Holdings, Inc. leads on 4 and NeuroSense Therapeutics Ltd. on 3.

Valuation

Metric NRSN RVPH Biotechnology median
P/E n/m n/m 8.58
P/S n/m n/m 10.29
P/B n/m 0.42 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m 0.58 0.67
EV/Sales n/m n/m 9.89
Earnings yield (520.49%) (252.17%) (31.56%)
Free cash flow yield (568.39%) (272.92%) (23.42%)

Profitability

Metric NRSN RVPH Biotechnology median
Gross margin — — 65.77%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (176.60%) (54.09%)
Return on assets 0.00% (79.46%) (47.78%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRSN RVPH Biotechnology median
Revenue growth (TTM) — — 5.83%
EPS growth (last fiscal year) 18.52% 69.56% 29.36%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRSN RVPH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.28 3.56 4.80
Net debt to EBITDA 0.01 0.71 0.97

Dividend

Metric NRSN RVPH Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric NRSN RVPH Biotechnology median
Market cap 4.63m 5.00m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack